col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

200 Results       Page 1

Springer (Biomed Central Ltd.): BMC Medicine
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―16 Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study Rachael Pung, Hannah E. Clapham, Timothy W. Russell, Vernon J. Lee, Adam J. Kucharski
2 [GO] 2023―Mar―08 Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries Yang Liu, Simon R. Procter, Carl A. B. Pearson, Andrés Madriz Montero, Sergio Torres-Rueda, Elias Asfaw, et al. (+9)
3 [GO] 2023―Feb―28 Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19 Jie Wei, Weiya Zhang, Michael Doherty, Zachary S. Wallace, Jeffrey A. Sparks, Na Lu, et al. (+4)
4 [GO] 2023―Feb―16 Correction: Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
5 [GO] 2023―Jan―19 Ethnic inequalities in the impact of COVID-19 on primary care consultations: a time series analysis of 460,084 individuals with multimorbidity in South London Alice McGreevy, Marina Soley-Bori, Mark Ashworth, Yanzhong Wang, Emma Rezel-Potts, Stevo Durbaba, et al. (+2)
6 [GO] 2023―Jan―19 Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England Ellen Brooks-Pollock, Kate Northstone, Lorenzo Pellis, Francesca Scarabel, Amy Thomas, Emily Nixon, et al. (+6)
7 [GO] 2023―Jan―08 Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study Matthew L. Bosworth, Tamanna Ahmed, Tim Larsen, Luke Lorenzi, Jasper Morgan, Raghib Ali, et al. (+8)
8 [GO] 2023―Jan―04 Individual and neighborhood risk factors of hospital admission and death during the COVID-19 pandemic: a population-based cohort study Max Bell, Maria-Pia Hergens, Stefan Fors, Per Tynelius, Antonio Ponce de Leon, Anton Lager
9 [GO] 2022―Dec―08 Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, et al. (+8)
10 [GO] 2022―Nov―30 Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test Manjula D. Nugawela, Terence Stephenson, Roz Shafran, Bianca L. De Stavola, Shamez N. Ladhani, Ruth Simmons, et al. (+8)
11 [GO] 2022―Nov―30 Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi, Chankyu Lee, Jeong-Yoon Lee, Kazutoyo Miura, et al. (+11)
12 [GO] 2022―Nov―25 Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression Marek Petráš, Roman Máčalík, Daniela Janovská, Alexander M. Čelko, Jana Dáňová, Eliška Selinger, et al. (+6)
13 [GO] 2022―Nov―24 Prognostic models for COVID-19 needed updating to warrant transportability over time and space David van Klaveren, Theodoros P. Zanos, Jason Nelson, Todd J. Levy, Jinny G. Park, Isabel R. A. Retel Helmrich, et al. (+5)
14 [GO] 2022―Nov―24 Economic evaluation of COVID-19 rapid antigen screening programs in the workplace Thomas N. Vilches, Ellen Rafferty, Chad R. Wells, Alison P. Galvani, Seyed M. Moghadas
15 [GO] 2022―Nov―16 Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
16 [GO] 2022―Nov―15 Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis Ting Zhang, Qimin Mei, Zhaocai Zhang, Joseph Harold Walline, Yecheng Liu, Huadong Zhu, Shuyang Zhang
17 [GO] 2022―Nov―15 Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants Yan Wang, Kaiyuan Sun, Zhaomin Feng, Lan Yi, Yanpeng Wu, Hengcong Liu, et al. (+4)
18 [GO] 2022―Nov―14 Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries C. Finn McQuaid, Marc Y. R. Henrion, Rachael M. Burke, Peter MacPherson, Rebecca Nzawa-Soko, Katherine C. Horton
19 [GO] 2022―Nov―08 Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, et al. (+11)
20 [GO] 2022―Nov―08 Lower transmissibility of SARS-CoV-2 among asymptomatic cases: evidence from contact tracing data in Oslo, Norway Fredrik Methi, Elisabeth Henie Madslien
21 [GO] 2022―Nov―02 Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study Anouk Verveen, Elke Wynberg, Hugo D. G. van Willigen, Udi Davidovich, Anja Lok, Eric P. Moll van Charante, et al. (+49)
22 [GO] 2022―Oct―25 Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis Bingyi Yang, Xiaotong Huang, Huizhi Gao, Nancy H. Leung, Tim K. Tsang, Benjamin J. Cowling
23 [GO] 2022―Oct―24 Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study Ewoud Schuit, Roderick P. Venekamp, Irene K. Veldhuijzen, Wouter van den Bijllaardt, Suzan D. Pas, Joep J. J. M. Stohr, et al. (+12)
24 [GO] 2022―Oct―20 Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death Zhuoying Huang, Shuangfei Xu, Jiechen Liu, Linlin Wu, Jing Qiu, Nan Wang, et al. (+8)
25 [GO] 2022―Oct―14 Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients Carlos King Ho Wong, David Tak Wai Lui, Xi Xiong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, et al. (+9)
26 [GO] 2022―Oct―13 Sustained seropositivity up to 20.5 months after COVID-19 Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Rocío Rubio, Gemma Ruiz-Olalla, Josep Vidal-Alaball, et al. (+14)
27 [GO] 2022―Oct―12 Characterising social contacts under COVID-19 control measures in Africa Zlatina Dobreva, Amy Gimma, Hana Rohan, Benjamin Djoudalbaye, Akhona Tshangela, Christopher I. Jarvis, et al. (+2)
28 [GO] 2022―Oct―10 Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study Neyme Veli, Christopher A. Martin, Katherine Woolf, Joshua Nazareth, Daniel Pan, Amani Al-Oraibi, et al. (+18)
29 [GO] 2022―Oct―05 The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Trung T. Tran, Siri Mjaaland, et al. (+13)
30 [GO] 2022―Oct―03 Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa Kesego Tapela, Fatima O. Oyawoye, Charles Ochieng’ Olwal, Precious C. Opurum, Jones Amo Amponsah, Kekeli Aku Lumor Segbedzi, et al. (+13)
31 [GO] 2022―Sep―27 A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, et al. (+8)
32 [GO] 2022―Sep―26 Transparency and reporting characteristics of COVID-19 randomized controlled trials Philipp Kapp, Laura Esmail, Lina Ghosn, Philippe Ravaud, Isabelle Boutron
33 [GO] 2022―Sep―21 The UK Coronavirus Job Retention Scheme and smoking, alcohol consumption and vaping during the COVID-19 pandemic: evidence from eight longitudinal population surveys Michael J. Green, Jane Maddock, Giorgio Di Gessa, Bożena Wielgoszewska, Sam Parsons, Gareth J. Griffith, et al. (+13)
34 [GO] 2022―Sep―20 Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study Anton Barchuk, Mikhail Cherkashin, Anna Bulina, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, et al. (+3)
35 [GO] 2022―Sep―16 SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, Gemma Castaño-Vinyals, Rocío Rubio, Marta Vidal, et al. (+20)
36 [GO] 2022―Sep―14 Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic Marc-Antoine Sanchez, Basile Fuchs, Pascale Tubert-Bitter, Anne-Sophie Mariet, Fabrice Jollant, Aurélie Mayet, Catherine Quantin
37 [GO] 2022―Sep―02 Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021 Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, et al. (+3)
38 [GO] 2022―Sep―02 Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients Flávio de Azevedo Figueiredo, Lucas Emanuel Ferreira Ramos, Rafael Tavares Silva, Daniela Ponce, Rafael Lima Rodrigues de Carvalho, Alexandre Vargas Schwarzbold, et al. (+62)
39 [GO] 2022―Aug―23 Genetic predispositions to psychiatric disorders and the risk of COVID-19 Wenwen Chen, Yu Zeng, Chen Suo, Huazhen Yang, Yilong Chen, Can Hou, et al. (+8)
40 [GO] 2022―Jul―30 Correction: The UK Coronavirus Job Retention Scheme and diet, physical activity, and sleep during the COVID-19 pandemic: evidence from eight longitudinal population surveys Bożena Wielgoszewska, Jane Maddock, Michael J. Green, Giorgio Di Gessa, Sam Parsons, Gareth J. Griffith, et al. (+12)
41 [GO] 2022―Jul―05 Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY Amelia Green, Helen Curtis, William Hulme, Elizabeth Williamson, Helen McDonald, Krishnan Bhaskaran, et al. (+35)
42 [GO] 2022―Jun―28 Helminth antigens differentially modulate the activation of CD4+ and CD8+ T lymphocytes of convalescent COVID-19 patients in vitro Tomabu Adjobimey, Julia Meyer, Vedrana Terkeš, Marijo Parcina, Achim Hoerauf
43 [GO] 2022―Jun―20 Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas Jacob Blankenberger, Marco Kaufmann, Emiliano Albanese, Rebecca Amati, Daniela Anker, Anne-Linda Camerini, et al. (+14)
44 [GO] 2022―May―23 Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic Aurélie Godbout, Mélanie Drolet, Myrto Mondor, Marc Simard, Chantal Sauvageau, Gaston De Serres, Marc Brisson
45 [GO] 2022―May―23 Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis Baoqi Zeng, Le Gao, Qingxin Zhou, Kai Yu, Feng Sun
46 [GO] 2022―May―18 An assessment of the vaccination of school-aged children in England against SARS-CoV-2 Matt J. Keeling, Sam E. Moore
47 [GO] 2022―May―04 Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, et al. (+10)
48 [GO] 2022―May―02 The COVID-19 pandemic in the African continent Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, Felix Ocom, Joseph F. Wamala, Kwadwo A. Kusi, et al. (+4)
49 [GO] 2022―Apr―26 Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis Nanina Anderegg, Radoslaw Panczak, Matthias Egger, Nicola Low, Julien Riou
50 [GO] 2022―Apr―15 Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia’s surveillance system performance Kamalini Lokuge, Katina D’Onise, Emily Banks, Tatum Street, Sydney Jantos, Mohana Baptista, Kathryn Glass
51 [GO] 2022―Apr―06 The UK Coronavirus Job Retention Scheme and diet, physical activity, and sleep during the COVID-19 pandemic: evidence from eight longitudinal population surveys Bożena Wielgoszewska, Jane Maddock, Michael J. Green, Giorgio Di Gessa, Sam Parsons, Gareth J. Griffith, et al. (+12)
52 [GO] 2022―Apr―05 CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study Enny S. Paixao, Kerry L. M. Wong, Flavia Jôse Oliveira Alves, Vinicius de Araújo Oliveira, Thiago Cerqueira-Silva, Juracy Bertoldo Júnior, et al. (+9)
53 [GO] 2022―Apr―04 Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study Zhiyuan Chen, Wen Zheng, Qianhui Wu, Xinghui Chen, Cheng Peng, Yuyang Tian, et al. (+14)
54 [GO] 2022―Mar―29 Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients Emily Toscano-Guerra, Mónica Martínez Gallo, Iria Arrese-Muñoz, Anna Giné, Noelia Díaz-Troyano, Pablo Gabriel-Medina, et al. (+10)
55 [GO] 2022―Mar―28 AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2 Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan Mandolo, Tandile Hermanaus, Thopisang Motlou, et al. (+17)
56 [GO] 2022―Mar―17 Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization Carlos King Ho Wong, Xi Xiong, Kristy Tsz Kwan Lau, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, et al. (+6)
57 [GO] 2022―Mar―03 Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Henrike Maass, et al. (+22)
58 [GO] 2022―Mar―02 Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases Luuk Wieske, Laura Y. L. Kummer, Koos P. J. van Dam, Eileen W. Stalman, Anneke J. van der Kooi, Joost Raaphorst, et al. (+47)
59 [GO] 2022―Feb―24 Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study Roderick P. Venekamp, Irene K. Veldhuijzen, Karel G. M. Moons, Wouter van den Bijllaardt, Suzan D. Pas, Esther B. Lodder, et al. (+12)
60 [GO] 2022―Feb―23 The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave Daniela Basso, Ada Aita, Filippo Navaglia, Paola Mason, Stefania Moz, Alessio Pinato, et al. (+9)
61 [GO] 2022―Feb―23 Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study Mario Rivera-Izquierdo, Antonio Jesús Láinez-Ramos-Bossini, Inmaculada Guerrero-Fernández de Alba, Rocío Ortiz-González-Serna, Álvaro Serrano-Ortiz, Nicolás Francisco Fernández-Martínez, et al. (+2)
62 [GO] 2022―Feb―22 Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) Mohammad Talaei, Sian Faustini, Hayley Holt, David A. Jolliffe, Giulia Vivaldi, Matthew Greenig, et al. (+12)
63 [GO] 2022―Feb―21 Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level Sophie Meakin, Sam Abbott, Nikos Bosse, James Munday, Hugo Gruson, Joel Hellewell, et al. (+46)
64 [GO] 2022―Feb―18 A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial Jorge B. Cannata-Andía, Augusto Díaz-Sottolano, Pehuén Fernández, Carmen Palomo-Antequera, Pablo Herrero-Puente, Ricardo Mouzo, et al. (+15)
65 [GO] 2022―Feb―18 Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis George J. Milne, Julian Carrivick, David Whyatt
66 [GO] 2022―Feb―08 Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study Giovanni Corrao, Matteo Franchi, Federico Rea, Danilo Cereda, Antonio Barone, Catia Rosanna Borriello, et al. (+13)
67 [GO] 2022―Feb―07 Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia Donal Bisanzio, Richard Reithinger, Ada Alqunaibet, Sami Almudarra, Reem F. Alsukait, Di Dong, et al. (+3)
68 [GO] 2022―Jan―31 Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China Hengcong Liu, Juanjuan Zhang, Jun Cai, Xiaowei Deng, Cheng Peng, Xinghui Chen, et al. (+9)
69 [GO] 2022―Jan―28 Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint Xinhua Chen, Wei Wang, Xinghui Chen, Qianhui Wu, Ruijia Sun, Shijia Ge, et al. (+5)
70 [GO] 2022―Jan―26 Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Vittoria Colizza, Yazdan Yazdanpanah, Arnaud Fontanet, et al. (+2)
71 [GO] 2022―Jan―25 Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2 Rahul Ukey, Natalie Bruiners, Hridesh Mishra, Pankaj K. Mishra, Deborah McCloskey, Alberta Onyuka, et al. (+7)
72 [GO] 2022―Jan―21 Humoral immune response after different SARS-CoV-2 vaccination regimens Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
73 [GO] 2022―Jan―20 Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients Zhonghan Sun, Zhi-Gang Song, Chenglin Liu, Shishang Tan, Shuchun Lin, Jiajun Zhu, et al. (+13)
74 [GO] 2022―Jan―19 Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production Michael Müller, Johann Volzke, Behnam Subin, Silke Müller, Martina Sombetzki, Emil C. Reisinger, Brigitte Müller-Hilke
75 [GO] 2022―Jan―14 Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, Miriam A. Lynn, Zelalem A. Mekonnen, Arthur Eng Lip Yeow, et al. (+14)
76 [GO] 2022―Jan―13 Modelling upper respiratory viral load dynamics of SARS-CoV-2 Joseph D. Challenger, Cher Y. Foo, Yue Wu, Ada W. C. Yan, Mahdi Moradi Marjaneh, Felicity Liew, et al. (+3)
77 [GO] 2021―Dec―07 Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study Wenlong Zhu, Mengxi Zhang, Jinhua Pan, Ye Yao, Weibing Wang
78 [GO] 2021―Dec―01 Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review Nuru Saadi, Y-Ling Chi, Srobana Ghosh, Rosalind M. Eggo, Ciara V. McCarthy, Matthew Quaife, et al. (+3)
79 [GO] 2021―Nov―30 Within- and across-day patterns of interplay between depressive symptoms and related psychopathological processes: a dynamic network approach during the COVID-19 pandemic Omid V. Ebrahimi, Julian Burger, Asle Hoffart, Sverre Urnes Johnson
80 [GO] 2021―Nov―30 Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort Mélanie Deschasaux-Tanguy, Bernard Srour, Laurent Bourhis, Nathalie Arnault, Nathalie Druesne-Pecollo, Younes Esseddik, et al. (+88)
81 [GO] 2021―Nov―23 Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain Carlota Dobaño, Selena Alonso, Mariona Fernández de Sevilla, Marta Vidal, Alfons Jiménez, Gemma Pons Tomas, et al. (+29)
82 [GO] 2021―Nov―19 SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021 Jonathan Mandolo, Jacquline Msefula, Marc Y. R. Henrion, Comfort Brown, Brewster Moyo, Aubrey Samon, et al. (+17)
83 [GO] 2021―Nov―16 COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank Can Hou, Yihan Hu, Huazhen Yang, Wenwen Chen, Yu Zeng, Zhiye Ying, et al. (+6)
84 [GO] 2021―Nov―09 Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study Kathleen M. O’Reilly, Frank Sandman, David Allen, Christopher I. Jarvis, Amy Gimma, Amy Douglas, et al. (+8)
85 [GO] 2021―Oct―18 Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England Thomas F. D. Mason, Matt Whitston, Jack Hodgson, Ruth E. Watkinson, Yiu-Shing Lau, Omnia Abdulrazeg, Matt Sutton
86 [GO] 2021―Oct―14 Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study Philipp Kohler, Sabine Güsewell, Marco Seneghini, Thomas Egger, Onicio Leal, Angela Brucher, et al. (+15)
87 [GO] 2021―Oct―14 Individual social contact data and population mobility data as early markers of SARS-CoV-2 transmission dynamics during the first wave in Germany-an analysis based on the COVIMOD study Damilola Victoria Tomori, Nicole Rübsamen, Tom Berger, Stefan Scholz, Jasmin Walde, Ian Wittenberg, et al. (+6)
88 [GO] 2021―Oct―01 Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections Timothy Farinholt, Harsha Doddapaneni, Xiang Qin, Vipin Menon, Qingchang Meng, Ginger Metcalf, et al. (+9)
89 [GO] 2021―Sep―29 SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries Frederik Verelst, Lisa Hermans, Sarah Vercruysse, Amy Gimma, Pietro Coletti, Jantien A. Backer, et al. (+11)
90 [GO] 2021―Sep―24 The risk of COVID-19 in survivors of domestic violence and abuse Joht Singh Chandan, Anuradhaa Subramanian, Jaidev Kaur Chandan, Krishna M. Gokhale, Alecs Vitoc, Julie Taylor, et al. (+3)
91 [GO] 2021―Sep―17 Exiting the pandemic: Singapore style Dale Fisher, Kenneth Mak
92 [GO] 2021―Sep―14 In for the long-haul? Seropositivity and sequelae 1 year post COVID-19 Jeremy Werner Deuel, Patricia Schlagenhauf
93 [GO] 2021―Sep―10 Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data James D. Munday, Christopher I. Jarvis, Amy Gimma, Kerry L. M. Wong, Kevin van Zandvoort, Yang Liu, et al. (+42)
94 [GO] 2021―Aug―30 The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19: a national retrospective cohort study Harrison Wilde, Thomas Mellan, Iwona Hawryluk, John M. Dennis, Spiros Denaxas, Christina Pagel, et al. (+5)
95 [GO] 2021―Aug―27 Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence Marina Treskova-Schwarzbach, Laura Haas, Sarah Reda, Antonia Pilic, Anna Borodova, Kasra Karimi, et al. (+7)
96 [GO] 2021―Aug―27 Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study Thi Mui Pham, Hannan Tahir, Janneke H. H. M. van de Wijgert, Bastiaan R. Van der Roest, Pauline Ellerbroek, Marc J. M. Bonten, et al. (+2)
97 [GO] 2021―Aug―23 Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients Ioannis P. Trougakos, Evangelos Terpos, Christina Zirou, Aimilia D. Sklirou, Filia Apostolakou, Sentiljana Gumeni, et al. (+9)
98 [GO] 2021―Aug―22 Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic Terence J. Quin, Jennifer K. Burton, Ben Carter, Nicola Cooper, Kerry Dwan, Ryan Field, et al. (+9)
99 [GO] 2021―Aug―12 SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study Simon R. Procter, Kaja Abbas, Stefan Flasche, Ulla Griffiths, Brittany Hagedorn, Kathleen M. O’Reilly, et al. (+50)
100 [GO] 2021―Aug―09 One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection Yanfei Chen, Cheng Ding, Ling Yu, Wanru Guo, Xuewen Feng, Liang Yu, et al. (+14)
101 [GO] 2021―Jul―28 Evaluation of the safety profile of COVID-19 vaccines: a rapid review Qianhui Wu, Matthew Z. Dudley, Xinghui Chen, Xufang Bai, Kaige Dong, Tingyu Zhuang, et al. (+2)
102 [GO] 2021―Jul―26 Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals Elizabeth Fraley, Cas LeMaster, Eric Geanes, Dithi Banerjee, Santosh Khanal, Elin Grundberg, et al. (+2)
103 [GO] 2021―Jul―14 Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study Lijuan Xiong, Qian Li, Xiongjing Cao, Huangguo Xiong, Ming Huang, Fengwen Yang, et al. (+14)
104 [GO] 2021―Jul―13 Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts Thu Nguyen-Anh Tran, Nathan B. Wikle, Emmy Albert, Haider Inam, Emily Strong, Karel Brinda, et al. (+8)
105 [GO] 2021―Jul―09 The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases Muna Affara, Hakim Idris Lagu, Emmanuel Achol, Richard Karamagi, Neema Omari, Grace Ochido, et al. (+30)
106 [GO] 2021―Jun―28 Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19 Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Josep Vidal-Alaball, Gemma Ruiz-Olalla, Marta Vidal, et al. (+12)
107 [GO] 2021―Jun―23 Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study Paul M. McKeigue, David A. McAllister, David Caldwell, Ciara Gribben, Jen Bishop, Stuart McGurnaghan, et al. (+9)
108 [GO] 2021―Jun―18 Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout Bimandra A. Djaafara, Charles Whittaker, Oliver J. Watson, Robert Verity, Nicholas F. Brazeau, Dwi Oktavia, et al. (+16)
109 [GO] 2021―Jun―07 An analysis of school absences in England during the COVID-19 pandemic Emma Southall, Alex Holmes, Edward M. Hill, Benjamin D. Atkins, Trystan Leng, Robin N. Thompson, et al. (+3)
110 [GO] 2021―Jun―04 Renin-angiotensin system blockers and COVID-19 Emmanuelle Vidal-Petiot, Nathalie Gault
111 [GO] 2021―May―20 Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study Álvaro Romero-Duarte, Mario Rivera-Izquierdo, Inmaculada Guerrero-Fernández de Alba, Marina Pérez-Contreras, Nicolás Francisco Fernández-Martínez, Rafael Ruiz-Montero, et al. (+5)
112 [GO] 2021―May―17 Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales Mohammad A. Alsallakh, Shanya Sivakumaran, Sharon Kennedy, Eleftheria Vasileiou, Ronan A. Lyons, Chris Robertson, et al. (+2)
113 [GO] 2021―May―12 Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study Francisco J. de Abajo, Antonio Rodríguez-Miguel, Sara Rodríguez-Martín, Victoria Lerma, Alberto García-Lledó
114 [GO] 2021―May―07 Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study Lloyd A. C. Chapman, Margot Kushel, Sarah N. Cox, Ashley Scarborough, Caroline Cawley, Trang Q. Nguyen, et al. (+4)
115 [GO] 2021―Apr―29 What neurological and psychiatric effects does COVID-19 have on its survivors? Alexios-Fotios A. Mentis
116 [GO] 2021―Apr―27 Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections Joel Hellewell, Timothy W. Russell, Rupert Beale, Gavin Kelly, Catherine Houlihan, Eleni Nastouli, Adam J. Kucharski
117 [GO] 2021―Apr―14 Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing Michael A. Johansson, Hannah Wolford, Prabasaj Paul, Pamela S. Diaz, Tai-Ho Chen, Clive M. Brown, et al. (+2)
118 [GO] 2021―Apr―09 Modeling the interplay between demography, social contact patterns, and SARS-CoV-2 transmission in the South West Shewa Zone of Oromia Region, Ethiopia Filippo Trentini, Giorgio Guzzetta, Margherita Galli, Agnese Zardini, Fabio Manenti, Giovanni Putoto, et al. (+8)
119 [GO] 2021―Mar―24 Greater public health impact of COVID-19 antigen detection tests Akiko Kowada
120 [GO] 2021―Mar―24 Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study Shiu Lun Au Yeung, Jie V Zhao, C Mary Schooling
121 [GO] 2021―Mar―09 Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis Saskia Ricks, Emily A. Kendall, David W. Dowdy, Jilian A. Sacks, Samuel G. Schumacher, Nimalan Arinaminpathy
122 [GO] 2021―Mar―05 Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study Marcello Morciano, Jonathan Stokes, Evangelos Kontopantelis, Ian Hall, Alex J. Turner
123 [GO] 2021―Feb―23 Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic Terence J. Quinn, Jennifer K. Burton, Ben Carter, Nicola Cooper, Kerry Dwan, Ryan Field, et al. (+9)
124 [GO] 2021―Feb―22 Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study Paul M. McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, Stuart J. McGurnaghan, David McAllister, et al. (+11)
125 [GO] 2021―Feb―20 Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission K. Lokuge, E. Banks, S. Davis, L. Roberts, T. Street, D. O’Donovan, et al. (+2)
126 [GO] 2021―Feb―20 The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment Christopher I. Jarvis, Amy Gimma, Kevin van Zandvoort, Kerry L. M. Wong, W. John Edmunds
127 [GO] 2021―Feb―10 Who should be prioritized for COVID-19 vaccination in China? A descriptive study Juan Yang, Wen Zheng, Huilin Shi, Xuemei Yan, Kaige Dong, Qian You, et al. (+7)
128 [GO] 2021―Feb―05 COVID-19 pandemic and violence: rising risks and decreasing urgent care-seeking for sexual assault and domestic violence survivors Katherine A. Muldoon, Kathryn M. Denize, Robert Talarico, Deshayne B. Fell, Agnes Sobiesiak, Melissa Heimerl, Kari Sampsel
129 [GO] 2021―Feb―05 The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories Yang Liu, Christian Morgenstern, James Kelly, Rachel Lowe, Mark Jit
130 [GO] 2021―Feb―03 The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya C. N. Mburu, J. Ojal, R. Chebet, D. Akech, B. Karia, J. Tuju, et al. (+12)
131 [GO] 2021―Jan―28 When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition Paula Littlejohn, B. Brett Finlay
132 [GO] 2021―Jan―28 Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures Sahamoddin Khailaie, Tanmay Mitra, Arnab Bandyopadhyay, Marta Schips, Pietro Mascheroni, Patrizio Vanella, et al. (+3)
133 [GO] 2021―Jan―22 Efficient SARS-CoV-2 surveillance strategies to prevent deadly outbreaks in vulnerable populations Damon J. A. Toth, Karim Khader
134 [GO] 2021―Jan―21 Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study Ewan Carr, Rebecca Bendayan, Daniel Bean, Matt Stammers, Wenjuan Wang, Huayu Zhang, et al. (+42)
135 [GO] 2021―Jan―12 Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19 Francesco Pinotti, Paul S. Wikramaratna, Uri Obolski, Robert S. Paton, Daniel S. C. Damineli, Luiz C. J. Alcantara, et al. (+3)
136 [GO] 2020―Dec―18 Cardiovascular implications of COVID-19 versus influenza infection: a review Muhammad Shahzeb Khan, Izza Shahid, Stefan D. Anker, Scott D. Solomon, Orly Vardeny, Erin D. Michos, et al. (+2)
137 [GO] 2020―Dec―18 Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study A. Vilches-Moraga, A. Price, P. Braude, L. Pearce, R. Short, A. Verduri, et al. (+11)
138 [GO] 2020―Dec―17 Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study Theodora Oikonomidi, Isabelle Boutron, Olivier Pierre, Guillaume Cabanac, Philippe Ravaud
139 [GO] 2020―Dec―16 Use of short message service in at-home COVID-19 patient management Paul Loubet, Christian Czeschan, Matthieu Sintes, Albert Sotto, Didier Laureillard
140 [GO] 2020―Dec―08 Optimizing COVID-19 surveillance in long-term care facilities: a modelling study David R. M. Smith, Audrey Duval, Koen B. Pouwels, Didier Guillemot, Jérôme Fernandes, Bich-Tram Huynh, et al. (+2)
141 [GO] 2020―Nov―25 Evidence for treatment with estradiol for women with SARS-CoV-2 infection Ute Seeland, Flaminia Coluzzi, Maurizio Simmaco, Cameron Mura, Philip E. Bourne, Max Heiland, et al. (+2)
142 [GO] 2020―Nov―16 Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, et al. (+19)
143 [GO] 2020―Nov―10 Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank Fanny Petermann-Rocha, Peter Hanlon, Stuart R. Gray, Paul Welsh, Jason M. R. Gill, Hamish Foster, et al. (+11)
144 [GO] 2020―Nov―04 Impact of Covid-19 in pregnancy on mother’s psychological status and infant’s neurobehavioral development: a longitudinal cohort study in China Yuanyuan Wang, Lian Chen, Tianchen Wu, Huifeng Shi, Qin Li, Hai Jiang, et al. (+5)
145 [GO] 2020―Nov―04 At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data Sue Mallett, A. Joy Allen, Sara Graziadio, Stuart A. Taylor, Naomi S. Sakai, Kile Green, et al. (+14)
146 [GO] 2020―Oct―29 Ending COVID-19: progress and gaps in research-highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings
147 [GO] 2020―Oct―23 Frailty as an integrative marker of physiological vulnerability in the era of COVID-19 Qian-Li Xue
148 [GO] 2020―Oct―22 Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections Timothy W. Russell, Nick Golding, Joel Hellewell, Sam Abbott, Lawrence Wright, Carl A. B. Pearson, et al. (+7)
149 [GO] 2020―Oct―19 Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China Rong Yang, Hui Mei, Tongzhang Zheng, Qiang Fu, Yiming Zhang, Stephen Buka, et al. (+9)
150 [GO] 2020―Oct―16 Adapting hospital capacity to meet changing demands during the COVID-19 pandemic Ruth McCabe, Nora Schmit, Paula Christen, Josh C. D’Aeth, Alessandra Løchen, Dheeya Rizmie, et al. (+9)
151 [GO] 2020―Oct―14 Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study Kevin van Zandvoort, Christopher I. Jarvis, Carl A. B. Pearson, Nicholas G. Davies, Ruwan Ratnayake, Timothy W. Russell, et al. (+5)
152 [GO] 2020―Oct―09 Response to COVID-19 in South Korea and implications for lifting stringent interventions Amy Dighe, Lorenzo Cattarino, Gina Cuomo-Dannenburg, Janetta Skarp, Natsuko Imai, Sangeeta Bhatia, et al. (+35)
153 [GO] 2020―Oct―05 The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements Matthew Quaife, Kevin van Zandvoort, Amy Gimma, Kashvi Shah, Nicky McCreesh, Kiesha Prem, et al. (+7)
154 [GO] 2020―Sep―12 Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, et al. (+16)
155 [GO] 2020―Sep―10 Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions Brennan C. Kahan, Tim P. Morris, Ian R. White, Conor D. Tweed, Suzie Cro, Darren Dahly, et al. (+4)
156 [GO] 2020―Sep―08 Preparing for a pandemic: highlighting themes for research funding and practice-perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) Alice Norton, Louise Sigfrid, Adeniyi Aderoba, Naima Nasir, Peter G. Bannister, Shelui Collinson, et al. (+7)
157 [GO] 2020―Sep―07 The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study Yao Ma, Lisha Hou, Xiufang Yang, Zhixin Huang, Xue Yang, Na Zhao, et al. (+5)
158 [GO] 2020―Sep―04 An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City Richard S. Whittle, Ana Diaz-Artiles
159 [GO] 2020―Sep―03 COVID-19 length of hospital stay: a systematic review and data synthesis Eleanor M. Rees, Emily S. Nightingale, Yalda Jafari, Naomi R. Waterlow, Samuel Clifford, Carl A. B. Pearson, et al. (+4)
160 [GO] 2020―Aug―21 Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009 Amanda M. Rojek, Genevieve E. Martin, Peter W. Horby
161 [GO] 2020―Aug―19 The effect of travel restrictions on the geographical spread of COVID-19 between large cities in China: a modelling study Billy J. Quilty, Charlie Diamond, Yang Liu, Hamish Gibbs, Timothy W. Russell, Christopher I. Jarvis, et al. (+7)
162 [GO] 2020―Aug―19 Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? Niraj Shenoy, Rebecca Luchtel, Perminder Gulani
163 [GO] 2020―Aug―14 Indirect implications of COVID-19 prevention strategies on non-communicable diseases Pietro A. Modesti, Jiguang Wang, Albertino Damasceno, Charles Agyemang, Luc Van Bortel, Alexandre Persu, et al. (+6)
164 [GO] 2020―Aug―06 Epidemiological and clinical features of pediatric COVID-19 Cheng-Xian Guo, Li He, Ji-Ye Yin, Xiang-Guang Meng, Wei Tan, Guo-Ping Yang, et al. (+4)
165 [GO] 2020―Jul―31 “The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic Hugo López-Pelayo, Henri-Jean Aubin, Colin Drummond, Geert Dom, Francisco Pascual, Jürgen Rehm, et al. (+3)
166 [GO] 2020―Jul―30 Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies Laura Di Domenico, Giulia Pullano, Chiara E. Sabbatini, Pierre-Yves Boëlle, Vittoria Colizza
167 [GO] 2020―Jul―30 Identifying and combating the impacts of COVID-19 on malaria Stephen J. Rogerson, James G. Beeson, Moses Laman, Jeanne Rini Poespoprodjo, Timothy William, Julie A. Simpson, Ric N. Price
168 [GO] 2020―Jul―24 Simulating the effect of school closure during COVID-19 outbreaks in Ontario, Canada Elaheh Abdollahi, Margaret Haworth-Brockman, Yoav Keynan, Joanne M. Langley, Seyed M. Moghadas
169 [GO] 2020―Jul―15 Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński
170 [GO] 2020―Jul―15 Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020 Kenji Mizumoto, Katsushi Kagaya, Gerardo Chowell
171 [GO] 2020―Jul―15 Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic Ioannis Kyrou, Emmanouil Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, Harpal S. Randeva
172 [GO] 2020―Jul―15 Systems and implementation science should be part of the COVID-19 response in low resource settings Mike English, Mosa Moshabela, Jacinta Nzinga, Edwine Barasa, Benjamin Tsofa, Bruno Marchal, Margaret E Kruk
173 [GO] 2020―Jul―15 Projected geographic disparities in healthcare worker absenteeism from COVID-19 school closures and the economic feasibility of child care subsidies: a simulation study Elizabeth T. Chin, Benjamin Q. Huynh, Nathan C. Lo, Trevor Hastie, Sanjay Basu
174 [GO] 2020―Jul―15 New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis Yuan Hou, Junfei Zhao, William Martin, Asha Kallianpur, Mina K. Chung, Lara Jehi, et al. (+4)
175 [GO] 2020―Jul―15 Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, et al. (+16)
176 [GO] 2020―Jul―01 Ethnicity and COVID-19 infection: are the pieces of the puzzle falling into place? Rachel H. Mulholland, Ian P. Sinha
177 [GO] 2020―Jun―29 Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales Mark D. Verhagen, David M. Brazel, Jennifer Beam Dowd, Ilya Kashnitsky, Melinda C. Mills
178 [GO] 2020―Jun―25 Rapid publications risk the integrity of science in the era of COVID-19 N. Bagdasarian, G. B. Cross, D. Fisher
179 [GO] 2020―Jun―25 A prospect on the use of antiviral drugs to control local outbreaks of COVID-19 Andrea Torneri, Pieter Libin, Joris Vanderlocht, Anne-Mieke Vandamme, Johan Neyts, Niel Hens
180 [GO] 2020―Jun―25 Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines Jillian C. Kohler, Tim K. Mackey
181 [GO] 2020―Jun―25 COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease Simon E. Brill, Hannah C. Jarvis, Ezgi Ozcan, Thomas L. P. Burns, Rabia A. Warraich, Lisa J. Amani, et al. (+4)
182 [GO] 2020―Jun―25 Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review Louise Sigfrid, Katherine Maskell, Peter G. Bannister, Sharif A. Ismail, Shelui Collinson, Sadie Regmi, et al. (+7)
183 [GO] 2020―Jun―09 COVID-19 cancer conundrum-evidence driving decisions or the lack of it? Nalinie Joharatnam-Hogan, Khurum Khan
184 [GO] 2020―Jun―08 Responding to COVID-19: how an academic infectious diseases division mobilized in Singapore Sophia Archuleta, Gail Cross, Jyoti Somani, Lionel Lum, Amelia Santosa, Rawan A. Alagha, et al. (+26)
185 [GO] 2020―Jun―05 The role of pulmonary CT scans for children during the COVID-19 pandemic Ian P. Sinha, Musa Kaleem
186 [GO] 2020―Jun―03 An evidence mapping and analysis of registered COVID-19 clinical trials in China Liming Lu, Fan Li, Hao Wen, Shuqi Ge, Jingchun Zeng, Wen Luo, et al. (+3)
187 [GO] 2020―Jun―03 Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020 Amna Tariq, Yiseul Lee, Kimberlyn Roosa, Seth Blumberg, Ping Yan, Stefan Ma, Gerardo Chowell
188 [GO] 2020―Jun―03 Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study Jichan Shi, Yang Li, Xian Zhou, Qiran Zhang, Xinchun Ye, Zhengxing Wu, et al. (+8)
189 [GO] 2020―Jun―03 Heterogenous COVID-19 transmission dynamics within Singapore: a clearer picture of future national responses N. Bagdasarian, D. Fisher
190 [GO] 2020―May―29 Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank Claire L. Niedzwiedz, Catherine A. O’Donnell, Bhautesh Dinesh Jani, Evangelia Demou, Frederick K. Ho, Carlos Celis-Morales, et al. (+6)
191 [GO] 2020―May―28 Diagnosis of COVID-19 in children: the story evolves R. Harwood, I. Sinha
192 [GO] 2020―May―27 Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach Alberto Aleta, Yamir Moreno
193 [GO] 2020―May―25 Epidemiological models are important tools for guiding COVID-19 interventions Robin N. Thompson
194 [GO] 2020―May―22 Africa’s response to COVID-19 Chikwe Ihekweazu, Emmanuel Agogo
195 [GO] 2020―May―07 Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK Christopher I. Jarvis, Kevin Van Zandvoort, Amy Gimma, Kiesha Prem, Petra Klepac, G. James Rubin, W. John Edmunds
196 [GO] 2020―May―06 A single-center, retrospective study of COVID-19 features in children: a descriptive investigation Huijing Ma, Jiani Hu, Jie Tian, Xi Zhou, Hui Li, Maxwell Thomas Laws, et al. (+6)
197 [GO] 2020―Apr―09 Medical education during pandemics: a UK perspective Areeb Mian, Shujhat Khan
198 [GO] 2020―Mar―18 Coronavirus: the spread of misinformation Areeb Mian, Shujhat Khan
199 [GO] 2020―Mar―13 What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures? Zhenjian He
200 [GO] 2020―Feb―28 Q&A: The novel coronavirus outbreak causing COVID-19 Dale Fisher, David Heymann

200 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec